Inactive

Announcement updated 18 May 2023 to include the following - All requests for full proposals have been sent out as applicable. If you did not receive one, do not invite letters will be sent out to all ... Announcement updated 18 May 2023 to include the following - All requests for full proposals have been sent out as applicable. If you did not receive one, do not invite letters will be sent out to all other white paper submitters OOA 30 June 2023. All other terms and conditions remain unchanged. 2022 FDA Broad Agency Announcement Day FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation. A recording of the full event (4 hours, 12 minutes), including closed captioning and an audio transcript, is now available. https://fda.zoomgov.com/rec/share/I3aM_Gjz7lAb3KVJmJI1lYV8Mqo3aGgL9_oI3jx6fFirkVz8Z9xKvxKWV4Pv5AJr.ubCqbg7TUd7XBSS2?startTime=1670338801000 Slides from this event are posted as well, under Event Materials. https://www.fda.gov/science-research/fda-broad-agency-announcement-day-2022-12062022 Additional Q&A attached. Announcment amendment 00002 updated to correct language on page 19. Announcement PDF updated to correct the Missing Information on Page 40, to update the research areas. Additionally, the BAA day question and answers have been added, as well as the list of awards from the 2022 BAA All other terms and conditions remain unchanged. Announcement PDF updated to correct the whitepaper due date to January 23rd, 2023. In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement. FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation. Join us to learn more about the FY 2023 BAA, and how to apply. Stay tuned. We'll add more information to this page, including how to attend this virtual event, as it becomes available. Link below: https://www.fda.gov/science-research/fda-broad-agency-announcement-day-2022-12062022